Last reviewed · How we verify
Medical prescription after ovulation — Competitive Intelligence Brief
phase 3
Reproductive Medicine / Fertility
Small molecule
Live · refreshed every 30 min
Target snapshot
Medical prescription after ovulation (Medical prescription after ovulation) — Peking University Third Hospital. A post-ovulation medical intervention designed to support luteal phase function and optimize conditions for embryo implantation.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Medical prescription after ovulation TARGET | Medical prescription after ovulation | Peking University Third Hospital | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Medical prescription after ovulation CI watch — RSS
- Medical prescription after ovulation CI watch — Atom
- Medical prescription after ovulation CI watch — JSON
- Medical prescription after ovulation alone — RSS
Cite this brief
Drug Landscape (2026). Medical prescription after ovulation — Competitive Intelligence Brief. https://druglandscape.com/ci/medical-prescription-after-ovulation. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab